[PHARMA] YoY Annualized Quarter Result on 31-Mar-2022 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-May-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
31-Mar-2022 [#1]
Profit Trend
QoQ- -35.56%
YoY- 19.87%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 3,521,816 3,848,696 3,173,996 3,279,684 3,144,432 2,471,692 2,473,176 6.06%
PBT 36,772 149,756 126,096 123,520 120,972 114,828 111,108 -16.82%
Tax -25,708 -34,332 -34,784 -33,860 -42,380 -44,472 -34,076 -4.58%
NP 11,064 115,424 91,312 89,660 78,592 70,356 77,032 -27.62%
-
NP to SH 10,592 110,936 92,544 89,596 78,468 70,344 75,692 -27.93%
-
Tax Rate 69.91% 22.93% 27.59% 27.41% 35.03% 38.73% 30.67% -
Total Cost 3,510,752 3,733,272 3,082,684 3,190,024 3,065,840 2,401,336 2,396,144 6.57%
-
Net Worth -142,812 413,947 355,919 350,047 528,825 524,838 544,360 -
Dividend
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Div - 41,918 41,872 62,695 62,521 51,964 41,475 -
Div Payout % - 37.79% 45.25% 69.98% 79.68% 73.87% 54.79% -
Equity
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Net Worth -142,812 413,947 355,919 350,047 528,825 524,838 544,360 -
NOSH 1,310,208 1,309,126 261,705 261,229 260,505 259,821 259,219 30.98%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin 0.31% 3.00% 2.88% 2.73% 2.50% 2.85% 3.11% -
ROE 0.00% 26.80% 26.00% 25.60% 14.84% 13.40% 13.90% -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
RPS 268.80 293.80 1,212.81 1,255.48 1,207.05 951.31 954.09 -19.02%
EPS 0.80 8.48 35.36 34.28 30.12 27.08 29.20 -45.07%
DPS 0.00 3.20 16.00 24.00 24.00 20.00 16.00 -
NAPS -0.109 0.316 1.36 1.34 2.03 2.02 2.10 -
Adjusted Per Share Value based on latest NOSH - 1,309,126
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
RPS 244.36 267.04 220.23 227.56 218.18 171.50 171.60 6.06%
EPS 0.73 7.70 6.42 6.22 5.44 4.88 5.25 -28.01%
DPS 0.00 2.91 2.91 4.35 4.34 3.61 2.88 -
NAPS -0.0991 0.2872 0.247 0.2429 0.3669 0.3642 0.3777 -
Price Multiplier on Financial Quarter End Date
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Date 31/03/23 31/03/22 31/03/21 31/03/20 29/03/19 30/03/18 31/03/17 -
Price 0.285 0.755 3.26 1.26 2.27 4.28 4.89 -
P/RPS 0.11 0.26 0.27 0.10 0.19 0.45 0.51 -22.55%
P/EPS 35.25 8.92 9.22 3.67 7.54 15.81 16.75 13.19%
EY 2.84 11.22 10.85 27.22 13.27 6.33 5.97 -11.64%
DY 0.00 4.24 4.91 19.05 10.57 4.67 3.27 -
P/NAPS 0.00 2.39 2.40 0.94 1.12 2.12 2.33 -
Price Multiplier on Announcement Date
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Date 18/05/23 20/05/22 21/05/21 19/05/20 16/05/19 16/05/18 16/05/17 -
Price 0.38 0.72 4.03 1.88 2.36 4.07 4.72 -
P/RPS 0.14 0.25 0.33 0.15 0.20 0.43 0.49 -18.83%
P/EPS 47.01 8.50 11.40 5.48 7.83 15.03 16.16 19.46%
EY 2.13 11.76 8.77 18.24 12.76 6.65 6.19 -16.28%
DY 0.00 4.44 3.97 12.77 10.17 4.91 3.39 -
P/NAPS 0.00 2.28 2.96 1.40 1.16 2.01 2.25 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment